Published financial brief
0052B
NEW FRONTIER HEALTH CORP
- As of
- 2020-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
4 data notes
- Only 3 of 5 periods.
- Input provenance requires review.
- A ratio denominator is near zero.
- One or more values are unavailable.
Exact-period record
Fundamentals
3 reported periods
| Metric | FY 20182018-12-31 | FY 20192019-12-31 | FY 20202020-12-31 |
|---|---|---|---|
| Financial statements | |||
| RevenueUSD millions | 0 | 351.8 | 344 |
| Cost of goods soldUSD millions | 0 | 264.2 | 244 |
| Selling, general and administrative expenseUSD millions | 0.6 | 32.2 | 45.1 |
| Depreciation and amortizationUSD millions | 0 | 49.5 | 64.7 |
| Net incomeUSD millions | 2.2 | -61.7 | -76.9 |
| Operating profit (EBIT)USD millions | -0.6 | 5.9 | -9.8 |
| Income taxesUSD millions | 0 | 8.9 | 4.2 |
| Short-term debtUSD millions | 0 | 70.5 | 14.5 |
| Long-term debtUSD millions | 0 | 534.6 | 555.4 |
| Cash and equivalentsUSD millions | 2.4 | 248.5 | 97.5 |
| ReceivablesUSD millions | 0 | 40.5 | 34.9 |
| InventoryUSD millions | 0 | 8.1 | 14 |
| PayablesUSD millions | 0.3 | 14.2 | 13.6 |
| Net property, plant and equipmentUSD millions | 0 | 536.5 | 557.9 |
| Capital expenditureUSD millions | 0 | 54.6 | 47.1 |
| Operating cash flowUSD millions | -0.4 | 33.9 | 40.4 |
| Prepaid expensesUSD millions | 0.1 | —missing | —missing |
| AccrualsUSD millions | 0.1 | 125.6 | 33.2 |
| EBITDAUSD millions | -0.6 | 55.4 | 54.9 |
| Working capitalUSD millions | 1.9 | 49.6 | 7.7 |
| Working capital requirementUSD millions | -0.3 | 34.4 | 35.4 |
| Total debtUSD millions | 0 | 605.1 | 569.9 |
| Free cash flowUSD millions | -0.4 | -20.7 | -6.7 |
| Unlevered free cash flowUSD millions | -0.6 | -34 | 6.9 |
| Returns and ratios | |||
| ROICratio | 185.4% | 0.2% | -0.3% |
| Pre-tax ROICratio | 185.4% | 0.2% | -0.3% |
| Effective tax rateratio | 0% | 0% | 0% |
| Revenue growthratio | —missing | —missing | -2.2% |
| EBIT / Revenueratio | —missing | 1.7% | -2.8% |
| Revenue / Invested capitalmultiple | 0× | 0.13× | 0.12× |
| Cogs Over Revenuesratio | —missing | 75.1% | 70.9% |
| Sga Over Revenuesratio | —missing | 9.1% | 13.1% |
| Da Over Revenuesratio | —missing | 14.1% | 18.8% |
| Nfa Over Revenuesratio | —missing | 152.5% | 162.2% |
| Wcr Over Revenuesratio | —missing | 9.8% | 10.3% |
| Debt Over Ebitdamultiple | —missing | 10.93× | 10.38× |
| St Debt Over Cashmultiple | 0× | 0.28× | 0.15× |
| Interest Over Ebitdamultiple | —missing | 0.28× | 0.73× |
| Interest Over Nocf Nicfmultiple | 0× | -0.75× | -5.99× |
| Nsf Over Wcrmultiple | 7.47× | -5.17× | -2.35× |
Ask this snapshot
Research assistant
0052B · annualSnapshot 6e07fb2e
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000